Haupt Pharma is now part of the Aenova Group. With a planned turnover of around 750million Euros in the current financial year, the Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry.
The group’s portfolio of services covers the entire value chain for the development and production of all main dosage forms and product groups in the field of medicines and dietary supplements.
The Aenova Group’s high standards of quality, innovative technologies and clear vision for the future has enabled it to become European market leader in the business-to-business field.
Headquartered near Munich, the Aenova Group operates 20 sites in seven countries throughout the world, and more than 4,000 employees contribute to the group’s success.
We are a strong partner, with more than 500 processed APIs and 1,500 products in more than 5000 presentations (SKUs). Our customers include more than 200 major pharmaceuticals companies from all over the world, which outsource the production of pharmaceuticals, OTC preparations, dietary supplements and specialised products. The Aenova Group delivers the highest standards in development and service support.